Immunotherapy

A combination of lenvatinib and pembrolizumab continued to provide a greater survival benefit than sunitinib among patients with advanced renal cell carcinoma, an updated analysis of the randomized phase 3 CLEAR study showed.

Survival for patients with metastatic colorectal cancer has improved steadily since 2012, according to retrospective study results.

Early efficacy in treatment may predict clinical response to subcutaneous immunotherapy for allergic rhinitis due to house dust mite allergy at 3 years, according to a letter published in Clinical and Translational Allergy.

Although immunotherapies have been a game-changer in cancer treatment, they do not work for all patients.

SAN ANTONIO — Allergen immunotherapy helped to relieve eosinophilic esophagitis symptoms and led to remission, according to results of a systematic review presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

A recent study published in JAMA Oncology showed the use of aggressive cancer treatment at the end of life has not decreased but rather shifted from chemotherapy to immunotherapy.

Increased awareness of the quality-of-life harm and financial burden associated with continued cancer treatment at the end of a patient’s life has led professional societies to promote reduced systemic anticancer therapy at this stage.

Healio compiled the most-read news in allergy, asthma and immunology posted in January.

The addition of serplulimab to chemotherapy extended OS among patients with previously untreated extensive-stage small cell lung cancer, according to randomized phase 3 study results.

Richard D. Carvajal, MD, has been appointed deputy physician-in-chief and director of medical oncology at Northwell Health Cancer Institute.